Seeking Alpha: Castlight Health's Bizarre IPO Pricing And Recent Panic Selling Are Just Two Parts Of A Horrible Story
May. 9, 2014 8:51 AM ET | 5 comments | About: CSLT, Includes: AET, UNH
Subscribers to SA PRO had an early look at this article. Learn more about PRO »
Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. (More...)
•CSLT has a realistic chance at market open each day of not being in business.
•CSLT's operations have caused and are causing the company to produce massive net losses.
•I believe CSLT has unlimited downside, up to and including having no value at all.
Castlight Health Inc. (CSLT) held one of the most bizarre IPO's of recent memory on 3/14/2014 selling 11,100,000 shares of B Class stock at $16/share, which was above their $13-$15 initial projected range. Goldman Sachs and Morgan Stanley were the main underwriters handing the IPO.
Although on the surface nothing about the IPO seems unusual it becomes borderline bizarre when considering that the $16 pricing gave CSLT, a company who at the time had 2013 revenues of $13 million, net losses of $62 million, and an accumulated deficit of $131.2 million, a $1.5 billion valuation. Yes, billion. Had this valuation stood the company would have been valued at over 100x revenues, a statistic that I have come to learn has become a scarlet letter for stocks destined for the pink sheets, the average return for an IPO valued at over 100x revenues at IPO over the next three years was -92.5%